Dystrophin is a subsarcolemmal protein which is defective in Duchenne
and Becker muscular dystrophy (DMD/BMD), and in three animal models. C
linical manifestations of dystrophin deficiency in humans range from a
mild calf muscle hypertrophy with cramps to the classical progressive
degenerative hypertrophic myopathy of Duchenne. A common feature in t
he clinical presentation of dystrophin deficiency in humans and in the
three documented animal models is the presence of muscle fibre hypert
rophy. This paper explores the hypothesis that membrane-bound signalli
ng processes are disrupted in the absence of dystrophin, and suggests
that these abnormalities may contribute to both the hypertrophic and d
egenerative changes of dystrophin deficiency.